Open loot of Pharmaceutical Companies.

Pawan Kumar Bansal: Gustakhi Maaf Haryana

Open loot of Pharmaceutical Companies.How pharma companies are minting money/ cheating ailing patients by circumventing legal provisions of the statues is evident from this life- saving drug product ( a forth generation antibiotic) mostly given post surgery.

This formulation contains “Meropenem” which is active pharm ingredient required by the body as it is therapeutical active. While Disodium EDTA is inactive and not required by the body as well the formulation. It appears to have been added in the product to circumvent clutches of DPCO 2013- a central price control order/law under Essential Commodity Act 1956.

The manufacturer has labeled its MRP as Rs 5400/- while as per DPCO 2013, it should have been around 1000/-.
This is a ploy to get out of DPCO 2013.

This amounts to cheating to the ailing mankind. Why additional unnecessary drug/salt (Disodium EDTA) is injected in to the body of patient (at MRP of 5400/- ) which is not needed.

As per the label it appears to be a product manufactured at a WHO-GMP Certified Pharma Unit ??.

CDSCO and State drug Regulators to look in to and save the poor patients from clutches of such unscrupulous manufacturer / marketers.
Retired Drugs Controller Haryana G K ,Singal told “ Gustakhi Maaf Haryana “There is need to curb such malpractice by the Drug regulators entrusted with duties under Drugs Act.

Related Posts

PGIMS recalls drug amid probe into deaths

The PGIMS authorities have directed all departments to immediately stop using a specific batch of injectable Propofol, an anaesthetic drug, and return the available stock to the central store. The…

NPPA list brings little relief: No price cut for 25% cancer drugs

Mumbai: Nearly one in four cancer drug packs in a revised price list issued by the National Pharmaceutical Pricing Authority (NPPA) has seen no reduction in maximum retail price (MRP),…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PGIMS recalls drug amid probe into deaths

PGIMS recalls drug amid probe into deaths

NPPA list brings little relief: No price cut for 25% cancer drugs

NPPA list brings little relief: No price cut for 25% cancer drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

For Aakash Healthcare, Community People are Apples of its Eyes

For Aakash Healthcare, Community People are Apples of its Eyes

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Yashoda Medicity: Baby takes a Giant Step in just One Year

Yashoda Medicity: Baby takes a Giant Step in just One Year